155 related articles for article (PubMed ID: 23946868)
1. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers.
Peng M; Bakker JL; Dicioccio RA; Gille JJ; Zhao H; Odunsi K; Sucheston L; Jaafar L; Mivechi NF; Waisfisz Q; Ko L
Genes Cancer; 2013 Jan; 4(1-2):15-25. PubMed ID: 23946868
[TBL] [Abstract][Full Text] [Related]
2. GT198 Splice Variants Display Dominant-Negative Activities and Are Induced by Inactivating Mutations.
Peng M; Yang Z; Zhang H; Jaafar L; Wang G; Liu M; Flores-Rozas H; Xu J; Mivechi NF; Ko L
Genes Cancer; 2013 Jan; 4(1-2):26-38. PubMed ID: 23946869
[TBL] [Abstract][Full Text] [Related]
3.
Schubert S; Ripperger T; Rood M; Petkidis A; Hofmann W; Frye-Boukhriss H; Tauscher M; Auber B; Hille-Betz U; Illig T; Schlegelberger B; Steinemann D
Genes Cancer; 2017 Jan; 8(1-2):472-483. PubMed ID: 28435519
[No Abstract] [Full Text] [Related]
4. GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.
Yang Z; Peng M; Cheng L; Jones K; Maihle NJ; Mivechi NF; Ko L
Am J Pathol; 2016 May; 186(5):1340-50. PubMed ID: 27001628
[TBL] [Abstract][Full Text] [Related]
5. Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.
Peng M; Zhang H; Jaafar L; Risinger JI; Huang S; Mivechi NF; Ko L
J Biol Chem; 2013 Nov; 288(46):33387-97. PubMed ID: 24097974
[TBL] [Abstract][Full Text] [Related]
6. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
7. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan.
Rashid MU; Khan FA; Muhammad N; Loya A; Hamann U
Cancer Res Treat; 2019 Jul; 51(3):992-1000. PubMed ID: 30309218
[TBL] [Abstract][Full Text] [Related]
9. Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases.
Sørlie T; Andersen TI; Bukholm I; Børresen-Dale AL
Breast Cancer Res Treat; 1998 Apr; 48(3):259-64. PubMed ID: 9598872
[TBL] [Abstract][Full Text] [Related]
10. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of a human homologue of TBPIP, a BRCA1 locus-related gene.
Ijichi H; Tanaka T; Nakamura T; Yagi H; Hakuba A; Sato M
Gene; 2000 May; 248(1-2):99-107. PubMed ID: 10806355
[TBL] [Abstract][Full Text] [Related]
12. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.
Bowcock AM
Breast Cancer Res Treat; 1993 Nov; 28(2):121-35. PubMed ID: 8173065
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. GT198 Is a Target of Oncology Drugs and Anticancer Herbs.
Pang J; Gao J; Zhang L; Mivechi NF; Ko L
Front Oral Health; 2021 Jun; 2():. PubMed ID: 34476412
[TBL] [Abstract][Full Text] [Related]
16. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
17. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
[TBL] [Abstract][Full Text] [Related]
18. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U
Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917
[TBL] [Abstract][Full Text] [Related]
19. RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.
Clague J; Wilhoite G; Adamson A; Bailis A; Weitzel JN; Neuhausen SL
PLoS One; 2011; 6(9):e25632. PubMed ID: 21980511
[TBL] [Abstract][Full Text] [Related]
20. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis.
Zhang L; Wang Y; Rashid MH; Liu M; Angara K; Mivechi NF; Maihle NJ; Arbab AS; Ko L
Oncotarget; 2017 Aug; 8(31):51591-51607. PubMed ID: 28881671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
